Bontempo Ohly Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$238K Hold
3,796
0.11% 32
2025
Q4
$362K Hold
3,796
0.16% 30
2025
Q3
$371K Hold
3,796
0.16% 30
2025
Q2
$408K Hold
3,796
0.18% 30
2025
Q1
$383K Hold
3,796
0.18% 30
2024
Q4
$339K Hold
3,796
0.17% 31
2024
Q3
$318K Hold
3,796
0.15% 33
2024
Q2
$292K Hold
3,796
0.15% 32
2024
Q1
$260K Hold
3,796
0.13% 32
2023
Q4
$219K Hold
3,796
0.11% 36
2023
Q3
$200K Sell
3,796
-3,796
-50% -$199K 0.11% 35
2023
Q2
$411K Hold
7,592
0.2% 35
2023
Q1
$380K Buy
+7,592
New +$358K 0.19% 34

Other funds holding BSX

Bontempo Ohly Capital Management's BSX Position: Q1 2026 in Review

Bontempo Ohly Capital Management held its Boston Scientific (BSX) position steady in Q1 2026 at 3,796 shares worth $238K. The position accounts for 0.11% of the portfolio, ranked #32.

Bontempo Ohly Capital Management first reported a position in BSX in Q1 2023 and has held it in 13 quarters since. The position peaked at $411K in Q2 2023. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Bontempo Ohly Capital Management held 3,796 shares of Boston Scientific worth $238K as of Q1 2026.
  • Bontempo Ohly Capital Management left its Boston Scientific share count unchanged in Q1 2026.
  • Boston Scientific made up 0.11% of Bontempo Ohly Capital Management's portfolio in Q1 2026, its #32 holding.
  • Bontempo Ohly Capital Management first reported a position in Boston Scientific in Q1 2023 and has held it in 13 quarters since.
  • Bontempo Ohly Capital Management's Boston Scientific position peaked at $411K in Q2 2023.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bontempo Ohly Capital Management's 13F filing for Q1 2026, filed 15 May 2026.